Gene · 5889
Papers3,668
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,668
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The distinct landscape of tumor immune microenvironment in homologous recombination deficient cancers. | Biomark Res | 2025 | 40830526 | PubTator, text mining | PubMed |
| Multigene germline and somatic testing for epithelial ovarian cancer in China. | NPJ Precis Oncol | 2025 | 40804290 | PubTator, text mining | PubMed |
| A Novel Droplet Digital PCR Assay for BRCA1 and RAD51C Methylation: Advancing Homologous Recombination Deficiency Detection in Ovarian Cancer. | J Mol Diagn | 2025 | 40783114 | PubTator, text mining | PubMed |
| Real-World Data of Comprehensive Cancer Genomic Profiling Tests Performed in the Routine Clinical Setting in Sarcoma. | Cancer Med | 2025 | 40755265 | PubTator, text mining | PubMed |
| Genetic landscape of Pakistani familial breast cancer patients using multigene panel testing. | Int J Cancer | 2025 | 40749126 | PubTator, text mining | PubMed |
| Long-Term Outcomes After Kidney Transplantation in a Recipient With Birt-Hogg-Dubé Syndrome. | Case Rep Transplant | 2025 | 40740168 | PubTator, text mining | PubMed |
| Comprehensive review on Fanconi anemia: insights into DNA interstrand cross-links, repair pathways, and associated tumors. | Orphanet J Rare Dis | 2025 | 40739565 | PubTator, text mining | PubMed |
| Predictive value of homologous recombination-related gene mutations in survival outcomes of first-line nivolumab plus chemotherapy for gastric cancer. | Gastric Cancer | 2025 | 40719786 | PubTator, text mining | PubMed |
| LODESTAR: A Single-Arm Phase II Study of Rucaparib in Solid Tumors With Pathogenic Germline or Somatic Variants in Homologous Recombination Repair Genes. | JCO Precis Oncol | 2025 | 40632975 | PubTator, text mining | PubMed |
| AlphaMissense for Identifying Pathogenic Missense Mutations in DNA Damage Repair Genes in Cancer. | JCO Precis Oncol | 2025 | 40570257 | PubTator, text mining | PubMed |
| LncRNA-Encoded Micropeptides: Expression Validation, Translational Mechanisms, and Roles in Cellular Metabolism. | Int J Mol Sci | 2025 | 40565374 | PubTator, text mining | PubMed |
| Breast cancer germline multigene panel testing in mainstream oncology based on clinical-public health utility: ESMO Precision Oncology Working Group recommendations. | Ann Oncol | 2025 | 40523834 | PubTator, text mining | PubMed |
Recommendations for Clinical Molecular Laboratories for Detection of Homologous Recombination Deficiency in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, Association of Cancer Care Centers, and College of American Pathologists. | J Mol Diagn | 2025 | 40517897 | PubTator, text mining | PubMed |
| Risk of ovarian cancer in women with pelvic inflammatory disease and homologous recombination repair gene mutations under 55: a population-based cohort study. | J Gynecol Oncol | 2025 | 40517019 | PubTator, text mining | PubMed |
| Predictive value of BRCA1/RAD51C methylation in HGSOC - An ancillary study of the PAOLA-1/ENGOT-ov25 phase 3 trial. | Eur J Cancer | 2025 | 40513287 | PubTator, text mining | PubMed |
| Moderate-Low Risk Breast Cancer Gene Expression in a Romanian Population. | Int J Mol Sci | 2025 | 40508121 | PubTator, text mining | PubMed |
| RNF20-mediated H2B monoubiquitination protects stalled forks from degradation and promotes fork restart. | EMBO Rep | 2025 | 40495033 | PubTator, text mining | PubMed |
| Integrative multi-omics study identifies sex-specific molecular signatures and immune modulation in bladder cancer. | Front Bioinform | 2025 | 40458476 | PubTator, text mining | PubMed |
| The role of multi-organ cancer predisposition genes in the risk of inherited and histologically diverse gastric cancer. | EBioMedicine | 2025 | 40446793 | PubTator, text mining | PubMed |
| Clinicopathological Characteristics of Ovarian and Breast Cancer in PALB2, RAD51C, and RAD51D Germline Pathogenic Variant Carriers. | Genes (Basel) | 2025 | 40428378 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5889/papers?page=7